Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine‐based chemotherapy. BJS 2017; 104: 328-336.
Published: 15th February 2017
Authors: N. T. E. Bird, M. Elmasry, R. Jones, E. Psarelli, J. Dodd, H. Malik et al.
Human equilibrative nucleoside transporters (
A systematic review was performed, searching databases from January 1997 to January 2016. Articles pertaining to
Of 42 articles reviewed, eight were suitable for review, with seven selected for quantitative meta‐analysis. The total number of patients included in the meta‐analysis was 770 (405
You may also be interested in
Authors: K. Sasaki, G. A. Margonis, N. Andreatos, A. Wilson, M. Weiss, C. Wolfgang et al.
Notes: Anti‐angiogenesis antibody of benefit
Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases.
Authors: A. E. Vallance, J. vanderMeulen, A. Kuryba, I. D. Botterill, J. Hill, D. G. Jayne et al.
Notes: Better survival
Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.
Authors: B. C. Odisio, S. Yamashita, S. Y. Huang, S. Harmoush, S. E. Kopetz, K. Ahrar et al.
Notes: Mutant RAS poor prognostic factor
Authors: I. Tarantino, R. Warschkow, T. Hackert, B. M. Schmied, M. W. Büchler, O. Strobel et al.
Notes: Higher number, lower survival
Authors: V. Scuderi, L. Barkhatov, R. Montalti, F. Ratti, F. Cipriani, F. Pardo et al.
Notes: Lap equals open
Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model. BJS 2017; 104: 590-599.
Authors: P. B. Olthof, F. Huisman, F. G. Schaap, K. P. van Lienden, R. J. Bennink, R. F. van Golen et al.
Notes: May enhance liver regeneration
Population‐based study on resection rates and survival in patients with colorectal liver metastasis in Norway. BJS 2017; 104: 580-589.
Authors: J.‐H. Angelsen, A. Horn, H. Sorbye, G. E. Eide, I. M. Løes, A. Viste et al.
Notes: Variation among patients and regions
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma. BJS 2017; 104: 600-607.
Authors: D. Ansari, M. Bauden, S. Bergström, R. Rylance, G. Marko‐Varga, R. Andersson et al.
Notes: Size matters
Randomized clinical trial
Randomized clinical trial of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study). BJS 2017; 104: 525-535.
Authors: E. M. Wong‐Lun‐Hing, R. M. van Dam, G. J. P. van Breukelen, P. J. Tanis, F. Ratti, R. van Hillegersberg et al.
Notes: A lesson in trial design
Recurrence after resection with curative intent for distal cholangiocarcinoma. BJS 2017; 104: 426-433.
Authors: K. Komaya, T. Ebata, K. Shirai, S. Ohira, N. Morofuji, A. Akutagawa et al.
Notes: Adjuvant therapy warranted in selected patients
Effect of preoperative biliary drainage on bacterial flora in bile of patients with periampullary cancer. BJS 2017; 104: e182-e188.
Authors: F. Scheufele, L. Aichinger, C. Jäger, I. E. Demir, S. Schorn, M. Sargut et al.
Randomized clinical trial
Randomized clinical trial of extended versus single‐dose perioperative antibiotic prophylaxis for acute calculous cholecystitis. BJS 2017; 104: e151-e157.
Authors: C. S. Loozen, K. Kortram, V. N. N. Kornmann, B. van Ramshorst, B. Vlaminckx, C. A. J. Knibbe et al.
Notes: Single dose sufficient